BONSITY: The new name for Alvogen’s Teriparatide Injection 620 mcg/2.48 mL; same affordable alternative to FORTEO® (teriparatide injection)
Molecular model

What is BONSITY?

A trusted anabolic therapy for osteoporosis

The first FDA-approved alternative to FORTEO® (teriparatide injection), BONSITY builds on more than 20 years of real-world experience with teriparatide.123*

Lower-cost alternative for high-risk patients

BONSITY helps patients build new bone affordably—eligible, commercially insured patients pay as little as $0 through our Savings Program. That’s important for your patients with osteoporosis at high risk for fracture.

BONSITY delivers results for women and men with osteoporosis.1

See the data

Key features of BONSITY1

Active ingredient: Teriparatide
Indications: 3 patient populations
Dosing: 20 mcg once a day
Administration: Subcutaneous injection via single-patient-use pen

BONSITY builds bone for more patients

BONSITY is indicated for 3 patient populations1:

Middle-aged woman with red glasses and short dark hair and a red shirt
Actor portrayal.
Postmenopausal women with osteoporosis at high risk for fracture
Middle-aged man with a mustache wearing a blue plaid shirt
Actor portrayal.
Men with primary or hypogonadal osteoporosis at high risk for fracture
 A middle-aged woman with short gray hair in a navy blue sweater wrapping her arms around a middle-aged man in a light blue sweater with a white beard and glasses
Actor portrayals.
Men and women with glucocorticoid-associated osteoporosis who have a high risk for fracture

Access and affordability

79% of Medicare Part D lives have access to BONSITY.3

Explore coverage and savings

Proven efficacy and safety

BONSITY builds on more than 20 years of clinical experience.

See the data

Questions about BONSITY?

Connect with a representative to help your patients build new bone with BONSITY

Request a representative
Request
a Rep

References:

  1. BONSITY® [prescribing information]. Morristown, NJ: Alvogen, Inc.
  2. FORTEO® [prescribing information]. Indianapolis, IN: Eli Lilly and Company.
  3. Data on file. Alvogen, Inc.